Fig. 3From: Systems pharmacology based approach to investigate the in-vivo therapeutic efficacy of Albizia lebbeck (L.) in experimental model of Parkinson’s diseaseTime latency to reach the opposite platform in groups; values are expressed as mean ± SEM, n = 6. The intergroup variation was measure by Prism one-way ANOVA followed by tukey’s multiple comparison post-hoc test. **P 0.01 vs HPD group, ###P < 0.001 vs NC (Normal control)Back to article page